Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Managing Disease-Modifying Therapies and Breakthrough Activity in Multiple Sclerosis Patients During the COVID-19 Pandemic: Toward an Optimized Approach

Total article views   HTML views PDF downloads Totals
10,774 Dovepress* 9,640+ 1,437 11,077
PubMed Central* 1,134 319 1,453
Totals 10,774 1,756 12,530
*Since 22 July 2020
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar